Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication July 2, 2016
- Accepted for publication October 20, 2016
- Published online February 27, 2017.
Article Versions
- Latest version (January 10, 2017 - 12:08).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2016 American Association for Clinical Chemistry
Author Information
- Francesca Riva1,2,
- Francois-Clement Bidard1,3,*,
- Alexandre Houy4,
- Adrien Saliou1,
- Jordan Madic1,
- Aurore Rampanou1,5,
- Caroline Hego1,
- Maud Milder1,5,
- Paul Cottu3,
- Marie-Paule Sablin3,
- Anne Vincent-Salomon6,
- Olivier Lantz5,6,7,8,
- Marc-Henri Stern4,
- Charlotte Proudhon1 and
- Jean-Yves Pierga1,3,9
- 1 Laboratory of Circulating Tumor Biomarkers, Institut Curie, PSL Research University, SiRIC, Paris, France;
- 2 Department of Medical Oncology, San Gerardo Hospital, Monza, Italy;
- 3 Department of Medical Oncology, Institut Curie, PSL Research University, Paris, France;
- 4 INSERM U830, Institut Curie, PSL Research University, Paris, France;
- 5 INSERM CIC-BT 1428, Institut Curie, PSL Research University, Paris, France;
- 6 Department of Biopathology, Institut Curie, PSL Research University, Paris, France;
- 7 Department of Tumor Biology, Institut Curie, PSL Research University, Paris, France;
- 8 INSERM U932, Institut Curie, PSL Research University, Paris, France;
- 9 Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
- ↵* Address correspondence to this author at: Institut Curie, PSL Research University, Department of Medical Oncology, 26 rue d'Ulm, 75005 Paris, France. Fax +33-153-104-041; e-mail francois-clement.bidard{at}curie.fr.
In this issue
Patient-Specific Circulating Tumor DNA Detection during Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
